Ligand Pharmaceuticals Inc (LGND)

[S-BEES-BUMBLEBEE]

$LGNDZ / Ligand Pharmaceuticals Incorporated Roche Contingent Value - Institutional Ownership and Shareholders

Security $LGNDZ / Ligand Pharmaceuticals Incorporated Roche Contingent Value (53220K215)
President & CEO HIGGINS JOHN L
ISIN US53220K2151
LEI 5493008K7TB0IKP37H79
Industry Pharmaceutical Preparations
Institutional Owners 8
Institutional Shares 481,446 - 8% (ex 13D/G)

$LGND / Ligand Pharmaceuticals Incorporated (626 owners)
$LGNZZ / Ligand Pharmaceuticals Incorporated Beta Contingent Value (6 owners)
$LGNYZ / Ligand Pharmaceuticals Incorporated General Contingent Value (6 owners)
$LGNXZ / Ligand Pharmaceuticals Incorporated Glucagon Contingent Value (8 owners)

Institutional Ownership and Shareholders
$LGNDZ / Ligand Pharmaceuticals Incorporated Roche Contingent Value Institutional Ownership

Ligand Pharmaceuticals Incorporated Roche Contingent Value (US: $LGNDZ) has 8 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 481,446 shares. Largest shareholders include VEXMX - Vanguard Extended Market Index Fund Investor Shares, KINETICS PORTFOLIOS TRUST - Kinetics Medical Portfolio, FSMAX - Fidelity Extended Market Index Fund, Ancora Advisors, LLC, ONEQ - Fidelity Nasdaq Composite Index Tracking Stock, FNCMX - Fidelity Nasdaq Composite Index Fund, and Captrust Financial Advisors.

Ligand Pharmaceuticals Incorporated Roche Contingent Value (US: $LGNDZ) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.

Institutional Put/Call Ratio

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

13D/G Filings

We present 13D/G filings separately from the 13F filings because of the different treatement by the SEC. 13D/G filings can be filed by groups of investors (with one leading), whereas 13F filings cannot. This results in situations where an investor may file a 13D/G reporting one value for the total shares (representing all the shares owned by the investor group), but then file a 13F reporting a different value for the total shares (representing strictly their own ownership). This means that share ownership of 13D/G filings and 13F filings are oftentimes not directly comparable, so we present them separately.

13F and Fund Filings

Effective Date:

2021-03-01 NP VEXMX - Vanguard Extended Market Index Fund Investor Shares 395,811

2021-02-26 NP KINETICS PORTFOLIOS TRUST - Kinetics Medical Portfolio 44,000

2021-02-16 13F Captrust Financial Advisors 500

2021-02-12 13F Ancora Advisors, LLC 12,000

2021-01-20 NP FNCMX - Fidelity Nasdaq Composite Index Fund 1,518

2021-01-20 NP FSMAX - Fidelity Extended Market Index Fund 26,087

2021-01-20 NP ONEQ - Fidelity Nasdaq Composite Index Tracking Stock 1,530

Link: https://fintel.io/so/us/lgndz